Production (Stage)
bluebird bio, Inc.
BLUE
$4.97
-$0.01-0.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -199.98M | -240.72M | -292.83M | -319.25M | -300.65M |
| Total Depreciation and Amortization | 61.32M | 61.24M | 56.20M | 48.27M | 37.82M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 54.64M | 49.50M | 58.09M | 83.05M | 83.15M |
| Change in Net Operating Assets | -144.76M | -130.05M | -85.46M | -57.19M | -58.69M |
| Cash from Operations | -228.79M | -260.02M | -263.99M | -245.12M | -238.36M |
| Capital Expenditure | -1.68M | -2.60M | -3.33M | -5.09M | -5.73M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.34M | 6.50M | 8.55M | 71.92M | 77.89M |
| Cash from Investing | 7.65M | 3.90M | 5.22M | 66.84M | 72.16M |
| Total Debt Issued | 0.00 | 71.32M | 71.32M | 71.32M | 71.32M |
| Total Debt Repaid | -91.76M | -85.95M | -83.64M | -74.51M | -61.30M |
| Issuance of Common Stock | -- | -- | 118.23M | 118.23M | 118.23M |
| Repurchase of Common Stock | -- | -- | -- | -42.00K | -487.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 141.29M | 102.10M | 53.16M | 38.33M | 17.96M |
| Cash from Financing | 49.53M | 87.47M | 159.06M | 153.33M | 145.72M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -171.60M | -168.65M | -99.72M | -24.96M | -20.49M |